TOKYO, Apr 1, 2022 - (JCN Newswire via SEAPRWire.com) - Eisai Co., Ltd. announced today that Eisai has acquired a majority of the shares issued by Arteryex Inc., a company that plans and develops software related to digital solutions such as provision of medical information platforms, through purchase of shares and subscription of a third-party allocation of common shares, and made it a subsidiary, as of March 31, 2022. The two companies will work together to develop and provide PHR (Personal Health Record)-related services for patients, healthcare professionals and society at large. Eisai launched its medium-term business plan "EWAY Future & Beyond" in April 2021, where the perspective to be shifted from that of patients to The People or each consumer. With "empowering The People to realize their fullest life" as the vision, Eisai delivers not only pharmaceutical products but also solutions to The People, by utilizing the latest digital technology such as AI, and aims to remove the anxiety of The People.Arteryex has excellent software development capabilities and has developed its own PHR-related product services, including apps for storing and converting health-related inform...